Newsday |
Drug to treat advanced ovarian cancer gets early FDA approval
Newsday The Food and Drug Administration has approved the use of Zejula for women with advanced ovarian cancer. It is manufactured by Massachusetts-based Tesaro, which has not released the drug's launch price. Photo Credit: Tesaro. advertisement | advertise ... FDA Approves Niraparib for Recurrent Ovarian Cancer BRCA Testing Has Skyrocketed, but Misses High-Risk Women Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula |
from Health - Google News http://ift.tt/2oeCLnn
EmoticonEmoticon